Opportunity Information: Apply for CDC RFA DD11 1108
Apply for CDC RFA DD11 1108
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Blood Safety Surveillance among People with Blood Disorders" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.184 Disabilities Prevention.
- This funding opportunity was created on May 19, 2011 and posted on May 19, 2011.
- Applicants must submit their applications by Jul 18, 2011 500 Pm Eastern Standard Time. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $3,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- The number of recipients for this funding is limited to 10 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Blood Safety Surveillance among People with Blood Disorders" (Funding Opportunity Number CDC-RFA-DD11-1108) is a Centers for Disease Control and Prevention (CDC) discretionary funding program intended to strengthen and modernize blood safety surveillance for people who receive frequent transfusions. Its central purpose is to support non-research public health activities that help protect the safety of the nation's blood supply while also responding to changing and emerging blood safety priorities within heavily transfused patient populations, such as individuals living with inherited or acquired blood disorders. Because these patients are exposed to many blood products over time, they can face unique cumulative risks, and the program is designed to improve the systems and practices used to monitor, detect, and respond to transfusion-related safety concerns in these higher-risk settings.
The CDC planned to fund this work through cooperative agreements, which typically means awardees would not just receive money but would also coordinate closely with CDC staff on implementation, reporting, and priority-setting. The funding activity category is health, and the associated CFDA number is 93.184 (Disabilities Prevention), aligning the work with broader prevention and surveillance goals rather than clinical research. Importantly, the announcement specifies that the funded activities are non-research, emphasizing practical surveillance, data collection, monitoring, and program operations designed to generate actionable public health information.
Financially, the announcement projected an estimated total funding level of $3,000,000, with an expectation of around 10 awards. The stated award ceiling was $200,000, and the award floor was listed as $0, which generally signals that individual award sizes could vary depending on scope, applicant capacity, and CDC priorities. There was no cost sharing or matching requirement, reducing barriers for organizations that may not have access to additional funds to meet a match.
Eligibility was described as unrestricted, meaning it was open to any type of entity, with the caveat that applicants should check the announcement text for any clarifications in the "Additional Information on Eligibility" section. In practice, opportunities like this commonly attract applications from health departments, hospitals, academic medical centers, blood disorder treatment programs, blood banks, and nonprofit organizations with the infrastructure to run surveillance and manage sensitive health data. The core expectation is that recipients can carry out blood safety surveillance activities relevant to heavily transfused populations and can collaborate effectively with CDC.
From a timeline standpoint, the opportunity was posted on May 19, 2011, with an original and current closing date of July 18, 2011 at 5:00 PM Eastern Time, and it was archived on August 17, 2011. Applicants seeking the complete requirements, required components, and any programmatic specifics were directed to consult the full announcement. For help accessing the announcement or for general submission questions, the listed contact was the CDC Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS), reachable by phone at 770-488-2700.
Frequently Asked Questions (FAQs): Blood Safety Surveillance among People with Blood Disorders (CDC-RFA-DD11-1108)
What is the title and funding opportunity number for this grant?
The opportunity is titled "Blood Safety Surveillance among People with Blood Disorders" and the Funding Opportunity Number is CDC-RFA-DD11-1108.
Which federal agency is offering this grant?
This is a Centers for Disease Control and Prevention (CDC) discretionary funding opportunity.
What is the overall purpose of this funding opportunity?
The central purpose is to strengthen and modernize blood safety surveillance for people who receive frequent transfusions, helping protect the safety of the nation's blood supply while addressing changing and emerging blood safety priorities in heavily transfused patient populations.
Who is the program intended to benefit?
The program focuses on heavily transfused patient populations, including individuals living with inherited or acquired blood disorders, because repeated exposure to blood products over time can create unique cumulative risks.
Is this opportunity for research or non-research activities?
The announcement specifies the funded activities are non-research. It emphasizes practical public health surveillance, such as data collection, monitoring, detection, response, and program operations intended to produce actionable public health information.
What types of activities does the opportunity emphasize?
Based on the description, the emphasis is on surveillance-related work and operational public health activities that improve systems and practices to monitor, detect, and respond to transfusion-related safety concerns in higher-risk settings.
What funding mechanism is planned for awards?
The CDC planned to fund this work through cooperative agreements, which generally means recipients coordinate closely with CDC staff on implementation, reporting, and priority-setting rather than operating fully independently.
What is the funding activity category?
The funding activity category is health.
What is the CFDA number associated with this opportunity?
The associated CFDA number is 93.184 (Disabilities Prevention).
How much total funding was estimated for this opportunity?
The announcement projected an estimated total funding level of $3,000,000.
How many awards were expected?
The opportunity anticipated around 10 awards.
What is the maximum award amount (award ceiling)?
The stated award ceiling was $200,000.
What is the minimum award amount (award floor)?
The award floor was listed as $0, which typically indicates award amounts could vary depending on scope, applicant capacity, and CDC priorities.
Is cost sharing or matching required?
No. The announcement states there was no cost sharing or matching requirement.
Who is eligible to apply?
Eligibility was described as unrestricted, meaning it was open to any type of entity. Applicants were advised to review the announcement text for any clarifications in the "Additional Information on Eligibility" section.
What kinds of organizations commonly apply to opportunities like this?
While eligibility is stated as unrestricted, the description notes that opportunities like this commonly attract applications from organizations with the capacity to run surveillance and manage sensitive health data, such as health departments, hospitals, academic medical centers, blood disorder treatment programs, blood banks, and nonprofit organizations.
What capabilities are implied for applicants?
Recipients are expected to be able to carry out blood safety surveillance activities relevant to heavily transfused populations and to collaborate effectively with CDC under a cooperative agreement.
When was this funding opportunity posted?
The opportunity was posted on May 19, 2011.
What was the application deadline?
The original and current closing date was July 18, 2011 at 5:00 PM Eastern Time.
Was this opportunity archived?
Yes. It was archived on August 17, 2011.
Where should applicants look for complete requirements and required components?
Applicants were directed to consult the full announcement for complete requirements, required application components, and programmatic specifics.
Who can be contacted for help with the announcement or submission questions?
The listed contact was the CDC Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS), reachable by phone at 770-488-2700.
What makes this opportunity different from a typical grant where the recipient works independently?
The key difference highlighted is the cooperative agreement structure, which typically involves closer coordination with CDC staff on implementation, reporting, and priority-setting.
Why does the program focus on people who receive frequent transfusions?
The description explains that because these patients receive many blood products over time, they may face cumulative risks. The program is designed to improve how transfusion-related safety concerns are monitored, detected, and addressed in those higher-risk contexts.
Browse more opportunities from the same category: Health
Next opportunity: OVC FY 11 National Field Generated Training, Technical Assistance, and Demonstration Projects
Previous opportunity: Owens Tribal Environmental Education trip to Yosemite National Park on a quest for Native Plants and Animals
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DD11 1108
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DD11 1108) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIDCD Research On Hearing Health Care (R21/R33) Apply for RFA DC 12 003 Funding Number: RFA DC 12 003 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Craniofacial Malformations Information for Affected Families, Health Care Providers, and School Professionals Apply for CDC RFA DD11 1105 Funding Number: CDC RFA DD11 1105 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Addressing Immunization Disparities in Minority Populations Apply for CDC RFA IP11 1101 Funding Number: CDC RFA IP11 1101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Capacity Building Assistance (CBA) To Improve The Delivery And Effectiveness Of Human Immunodeficiency Virus (HIV) Prevention Services For High Risk And/Or Racial/Ethnic Minority Populations Apply for CDC RFA PS09 9060201SUPP11 Funding Number: CDC RFA PS09 9060201SUPP11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $103,550 |
| Systems for Improved Access to Pharmaceuticals and Services Apply for SOL OAA 11 000064 Funding Number: SOL OAA 11 000064 Agency: Agency for International Development Category: Health Funding Amount: $198,000,000 |
| FY11 OAH National Resource Center for HIV/AIDS Prevention among Adolescents Apply for AH TP2 11 001 Funding Number: AH TP2 11 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $200,000 |
| Technology Development for High Throughput Functional Genomics (R21) Apply for RFA HG 11 014 Funding Number: RFA HG 11 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technology Development for High Throughput Functional Genomics (R01) Apply for RFA HG 11 013 Funding Number: RFA HG 11 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technology Development for High Throughput Functional Genomics (R43/44) Apply for RFA HG 11 015 Funding Number: RFA HG 11 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| ORAL HEALTH TRAINING AND TECHNICAL ASSISTANCE NATIONAL COOPERATIVE AGREEMENT Apply for HRSA 11 180 Funding Number: HRSA 11 180 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Mechanistic Studies of HIV exposed Seronegative Individuals (HESN)(R21) Apply for PA 11 217 Funding Number: PA 11 217 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Mechanistic Studies of HIV exposed Seronegative Individuals (HESN) (R01) Apply for PA 11 218 Funding Number: PA 11 218 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Predictive Biodosimetry Discovery and Development of Biomarkers for Acute and Delayed Radiation Injuries (R01) Apply for RFA AI 11 033 Funding Number: RFA AI 11 033 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| FY11 Campus Men Supporting Womens Health Project (CMSWHP) Apply for WH HPP 11 001 Funding Number: WH HPP 11 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $240,000 |
| FY11 Health Care Provider Response to Violence Against Women Education, Training and Technical Assistance Program Apply for WH AST 11 001 Funding Number: WH AST 11 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,600,000 |
| FY11 Faith Advocates for Health Relationships Training and Technical Assistance Project Apply for WH AST 11 002 Funding Number: WH AST 11 002 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $300,000 |
| NIAMS Clinical Trial Implementation Cooperative Agreement (U01) Apply for PAR 11 219 Funding Number: PAR 11 219 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strategies for the Protection of Pregnant Women and Infants Against Infectious Diseases (R01) Apply for RFA AI 11 036 Funding Number: RFA AI 11 036 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Limited Competition NIMHD Endowment Program for Increasing Research and Institutional Resources Capacity (S21) Apply for RFA MD 11 006 Funding Number: RFA MD 11 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Therapeutics for Neurotropic Biodefense Toxins and Pathogens (R21/R33) Apply for RFA AI 11 027 Funding Number: RFA AI 11 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DD11 1108", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.